|
|
| allogeneic engineered natural killer cells and non-alpha beta T cells / Editas Medicine (0 Trials) |
|
| allogeneic fecal microbiota / St. Petersburg State Medical University (0 Trials) |
|
| allogeneic human dental pulp stem cells / Utooth Biological Technology, Wuhan University, Beijing SH Bio-Tech Corporation (0 Trials) |
|
| allogeneic human umbilical cord-derived mesenchymal stem cells (huMSC) / Medistem Panama (0 Trials) |
|
| allogeneic iPSC-derived natural killer cell immunotherapy / Shoreline Biosci (0 Trials) |
|
| allogeneic K562-GM tumor cell vaccine / National Cancer Institute (1 Trials) |
|
| allogeneic mesenchymal stromal cells / Pandorum Tech, Medical University of South Carolina (0 Trials) |
|
| allogeneic mesothelin targeting TRuC-T cell therapy / Adaptimmune (0 Trials) |
|
| allogeneic Myeloma GM-CSF Vaccine / Sidney Kimmel Comprehensive Cancer Center, BMS, Novartis (0 Trials) |
|
| allogeneic natural killer cell therapy / Green Cross Cell (0 Trials) |
|
| allogeneic NK transfer immunotherapy / National University of Colombia (0 Trials) |
|
| allogeneic ROR1-targeted CAR-NK cell therapy / Oncternal Therap (0 Trials) |
|
| allogeneic ROR1-targeted CAR-T / Oncternal Therap (0 Trials) |
|
| allogeneic tumor cell vaccine (PT 107) / Technomark Life Sci, Pique Therapeutics, Inc. (0 Trials) |
|
| allogeneic umbilical cord-derived mesenchymal stem cells (EN001) / ENCell (0 Trials) |
|
| Allogeneic Vγ9Vδ2+ γδT cells / GammaCell Bio (0 Trials) |
|
| allogeneic γδ T cell therapy / Chinese PLA General Hospital (0 Trials) |
|
| allogenic adipose tissue derived mesechymal stem cells / Andalusian Initiative for Advanced Therapies (0 Trials) |
|
| allogenic adipose tissue-derived mesenchymal stem cells expanded / ANd&tAT (0 Trials) |
|
| allogenic mesenchymal stem cells from adipose tissue / Andalusian Public Progress and Health Foundation (0 Trials) |
|
| allogenic NK cells therapy / Shandong University (0 Trials) |
|
| allogenic off-the-shelf mesenchymal stem cells-derived extracellular vesicles / Esperite (0 Trials) |
|
| Allogenic PEBL-CAR T / MediSix Therap (0 Trials) |
|
| AlloJoin (allogeneic human adipose-derived mesenchymal stem cell therapy) / Cellular Biomedicine (0 Trials) |
|
| AlloNK (GCC4001) / GC Biopharma (0 Trials) |
|
| allopregnanolone (LJPC-0712) / Innoviva (0 Trials) |
|
| allopregnanolone (LYT-300) / PureTech (0 Trials) |
|
| allopurinol / Generic mfg. (65 Trials) |
|
| AlloRx Stem Cell therapy / Vitro Biopharma (0 Trials) |
|
| Allose1000 / Ensol Biosci (0 Trials) |
|
| AlloStem (CELZ-201) / Creative Medical Technology (0 Trials) |
|
| allosteric LSD1 modulator / Beactica (0 Trials) |
|
| Allosteric Phosphatase Modulator / Anavo Therap (0 Trials) |
|
| AlloStim (bioengineered allogeneic immune cells) / Immunovative (2 Trials) |
|
| AlloVax (CRCL/AlloStim) / Immunovative (0 Trials) |
|
| Allovectin-7 (velimogene aliplasmid) / AnGes MG, Fresh Tracks Therap (0 Trials) |
|
| ALM201 / Almac Discovery (0 Trials) |
|
| ALM223 / Almirall (0 Trials) |
|
| ALM27134 / Almirall (0 Trials) |
|
| Almax (almagate) / Almirall (2 Trials) |
|
| ALMB-0166 / CSPC Pharma (0 Trials) |
|
| ALMB-0168 / CSPC Pharma (0 Trials) |
|
| almitrine / Public Assistance - Paris Hospitals (0 Trials) |
|
| almotriptan / Generic mfg. (2 Trials) |
|
| ALN-AAT / Alnylam (0 Trials) |
|
| ALN-AAT02 / Alnylam, Novo Nordisk (0 Trials) |
|
| ALN-AC3 / Alnylam (0 Trials) |
|
| ALN-ANG / Alnylam (0 Trials) |
|
| ALN-CC3 / Alnylam (0 Trials) |
|
| ALN-F12 / Alnylam (0 Trials) |
|
| ALN-HSD / Regeneron (0 Trials) |
|
| ALN-HTT / Regeneron, Alnylam (0 Trials) |
|
| ALN-KHK / Alnylam (0 Trials) |
|
| ALN-LEC / Alnylam (0 Trials) |
|
| ALN-PCS01 / Novartis (0 Trials) |
|
| ALN-PNP / Alnylam, Regeneron (0 Trials) |
|
| ALN-REGN1 / Alnylam, Regeneron (0 Trials) |
|
| ALN-REGN2 / Regeneron, Alnylam (0 Trials) |
|
| ALN-REGN3 / Alnylam, Regeneron (0 Trials) |
|
| ALN-REGN4 / Alnylam, Regeneron (0 Trials) |
|
| ALN-REGN5 / Alnylam, Regeneron (0 Trials) |
|
| ALN-SOD1 / Alnylam, Regeneron (0 Trials) |
|
| ALN-TMP / Alnylam (0 Trials) |
|
| ALN-TTRsc04 / Alnylam (0 Trials) |
|
| ALN-VIR2 / Alnylam, Vir Biotech (0 Trials) |
|
| ALN-VSP / Alnylam (0 Trials) |
|
| ALN-XDH / Alnylam (0 Trials) |
|
| alnuctamab (CC-93269) / BMS (0 Trials) |
|
| alobresib (GS-5829) / Gilead (0 Trials) |
|
| Alocrest (vinorelbine liposomal) / Assertio (0 Trials) |
|
| alofanib (RPT835) / R-Pharm (0 Trials) |
|
| Alofisel (darvadstrocel) / Takeda (5 Trials) |
|
| alogabat (RG7816) / Roche (0 Trials) |
|
| alogliptin/metformin extended release (CT-L01) / Celltrion (0 Trials) |
|
| alomfilimab (SAR445256) / Sanofi (0 Trials) |
|
| Alomide (lodoxamide tromethamine) / Novartis (0 Trials) |
|
| Alora (estradiol) / AbbVie (0 Trials) |
|
| alosetron / Generic mfg. (0 Trials) |
|
| Aloxi (palonosetron oral) / Helsinn, Otsuka, Roche, Eisai, Immedica (0 Trials) |
|
| Alpha 37 / Nordic Nanovector, Orano (0 Trials) |
|
| Alpha 7 / Bionomics (0 Trials) |
|
| Alpha Adrenergic Program / AbbVie, Acadia Pharma (0 Trials) |
|
| alpha glucosidase / Pharming Group (0 Trials) |
|
| alpha lactalbumin oleic acid (Alpha1H) / Linnane Pharma (0 Trials) |
|
| alpha-1 antitrypsin / iBio (0 Trials) |
|
| alpha-1 antitrypsin stimulant / Cloud Pharma (0 Trials) |
|
| alpha-1-antitrypsin inhalation (VR179) / Vectura, Grifols (0 Trials) |
|
| alpha-gal glycolipids (AGI-134) / BioLineRx (0 Trials) |
|
| alpha-galactosidase / iBio (0 Trials) |
|
| alpha-interferon / Jiangxi Qingfeng Pharma (0 Trials) |
|
| alpha-lactalbumin vaccine / Anixa Biosci, Cleveland Clinic (0 Trials) |
|
| alpha-synuclein targeted antibody / Eli Lilly (0 Trials) |
|
| alphalex-exatecan (CBX-12) / Cybrexa Therap (0 Trials) |
|
| AlphaMedix (ORM-2110) / RadioMedix, Orano (1 Trials) |
|
| Alphanate (human plasma derived von Willebrand factor/FVIII complex) / Grifols (2 Trials) |
|
| Alphanine SD (coagulation factor IX [human]) / (0 Trials) |
|
| Alpharen (fermagate) / OPKO Health (1 Trials) |
|
| alphataxin / Alpha-1 Biologics (0 Trials) |
|
| alpibectir (BVL-GSK098) / BioVersys, GSK (0 Trials) |
|
| ALPPL2 targeting CAR-T / University of California (0 Trials) |
|
| alprazolam / Generic mfg. (24 Trials) |
|
| alprazolam (ZRS 101) / Miravo (0 Trials) |
|
| Alprolix (eftrenonacog alfa) / SOBI, Sanofi (3 Trials) |
|
| alprostadil liposome / CSPC Pharma (0 Trials) |
|
| Alrex (loteprednol etabonate opthalmic suspension 0.2%) / Bausch Health (0 Trials) |
|
| alrizomadlin (APG-115) / Ascentage Pharma (0 Trials) |
|
| ALRN-5281 / Aileron (0 Trials) |
|
| ALRN-6924 / Aileron (3 Trials) |
|
| ALS therapeutic / AgoneX Biopharma (0 Trials) |
|
| ALS-00T2-0501 / Apollo Life Sciences (0 Trials) |
|
| ALS-205 / Alsonex (1 Trials) |
|
| ALS-2158 / J&J, Vertex (1 Trials) |
|
| ALS-2200 / J&J, Vertex, BMS (0 Trials) |
|
| ALS-4 / Aptorum Group (0 Trials) |
|
| ALS-SOD1 / Voyager (0 Trials) |
|
| alsevalimab (FPA150) / Amgen (0 Trials) |
|
| Alsuma (sumatriptan succinate subcutaneous injection) / Pfizer (0 Trials) |
|
| ALT 836 / ImmunityBio (0 Trials) |
|
| ALT-702 / Altimmune (0 Trials) |
|
| ALT-801 / ImmunityBio (0 Trials) |
|
| ALT-802 / ImmunityBio (0 Trials) |
|
| ALT-804 / ImmunityBio (0 Trials) |
|
| ALT-CP4 / Altay Therap (0 Trials) |
|
| ALT-L9 (aflibercept biosimilar) / Alteogen (0 Trials) |
|
| ALT-LS2 (trastuzumab SC biosimilar) / Alteogen (0 Trials) |
|
| ALT-P1 (somatropin biosimilar) / Alteogen, Korea Kolmar (0 Trials) |
|
| ALT-P7 / Alteogen (0 Trials) |
|
| ALT-Q5 / Alteogen (0 Trials) |
|
| ALT02 (trastuzumab biosimilar) / Alteogen, Qilu Pharma, Cristalia (1 Trials) |
|
| ALTA-002 / ALX Oncology, Tallac Therap (0 Trials) |
|
| ALTA-2530 / Sumitomo Pharma (0 Trials) |
|
| Altabax (retapamulin) / GSK, Almirall (0 Trials) |
|
| Altebrel (etanercept biosimilar) / AryoGen Pharmed (2 Trials) |
|
| Altemia (docosahexaenoic acid) / Micelle BioPharma (0 Trials) |
|
| alteminostat (CKD-581) / Chong Kun Dang (1 Trials) |
|
| Altepan / Apollo Endosurgery (0 Trials) |
|
| altiratinib (DCC-2701) / Ono Pharma (0 Trials) |
|
| ALTO-100 / Alto Neurosci (0 Trials) |
|
| ALTO-202 / Alto Neurosci (0 Trials) |
|
| ALTO-300 / Alto Neurosci (0 Trials) |
|
| Altoprev (lovastatin extended-release formulation) / AbbVie (1 Trials) |
|
| Altosone (mometasone) / Merck (MSD) (0 Trials) |
|
| Altreno (tretinoin) / Bausch Health (1 Trials) |
|
| Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl) / SOBI, Sanofi (3 Trials) |
|
| aluminum hydroxide/magnesium hydroxide / Generic mfg. (0 Trials) |
|
| alunacedase alfa (APN01) / Apeiron Biologics (0 Trials) |
|
| Alunbrig (brigatinib) / Takeda (23 Trials) |
|
| Alupent (metaproterenol) / Endo (0 Trials) |
|
| Alustal / Stallergenes (2 Trials) |
|
| ALVAC gp100 / Sanofi (0 Trials) |
|
| ALVAC-HIV / National Institute of Allergy and Infectious Diseases, Sanofi (1 Trials) |
|
| ALVAC-HIV (vCP2438)/Bivalent Subtype C gp120/MF59 / National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| alvelestat (MPH966) / Mereo Biopharma (2 Trials) |
|
| Alveritin (epoetin alfa biosimilar) / Alvartis (0 Trials) |
|
| Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center (6 Trials) |
|
| alvocidib (DSP-2033) / Sumitomo Pharma (1 Trials) |
|
| ALVR106 / AlloVir, Baylor College of Medicine (0 Trials) |
|
| ALVR107 / AlloVir (0 Trials) |
|
| ALVR109 / AlloVir (0 Trials) |
|
| ALW-II-41-27 / University of Naples Federico II (0 Trials) |
|
| ALX-001 / Allyx Therap (0 Trials) |
|
| ALX-029 / Alxerion (0 Trials) |
|
| ALX-0962 / Sanofi (0 Trials) |
|
| ALX-101 / Ralexar Therap (0 Trials) |
|
| ALX1 / KNOW Bio (0 Trials) |
|
| ALXN5500 / AstraZeneca (0 Trials) |
|
| Alyglo (human immune globulin IV 10%) / GC Biopharma (0 Trials) |
|
| Alymsys (bevacizumab-maly) / Amneal, Pharmaceutical Libbs, Grupo Insud, Nichi-Iko, Stada (1 Trials) |
|
| ALZ-101 / Alzinova (0 Trials) |
|
| ALZ-1903 / Alzheon (0 Trials) |
|
| ALZ-201 / Alzinova (0 Trials) |
|
| ALZ002 / AnnJi Pharma, Fortress (0 Trials) |
|
| Alzheimer's disease vaccine / SciSparc (0 Trials) |
|
| ALZN002 / Alzamend Neuro (0 Trials) |
|
| Alzumab (itolizumab) / Biocon, Equillium, Ono Pharma (4 Trials) |
|
| Alzyen (cetrizine) / Daewoong Pharma (0 Trials) |
|
| AM 095 / BMS (0 Trials) |
|
| AM 1476 / AnaMar (0 Trials) |
|
| AM 3710 / Amura (0 Trials) |
|
| AM 3840 / Amura (0 Trials) |
|
| AM-0422 / Amgen (0 Trials) |
|
| AM-0466 / Amgen (0 Trials) |
|
| AM-102 / Altamira Therap (0 Trials) |
|
| AM-168 / AcadeMab (0 Trials) |
|
| AM-3506 / National Institute on Alcohol Abuse and Alcoholism (0 Trials) |
|
| AM-5992 / Amgen (0 Trials) |
|
| AM-6120 / Amgen (0 Trials) |
|
| AM-8145 / Amgen (0 Trials) |
|
| AM-831 / Meiji Seika, Acadia Pharma (0 Trials) |
|
| AM-928 / AcadeMab (0 Trials) |
|
| AM-Laqer (amorolfine) / Sun Pharma (0 Trials) |
|
| AM0001 / Eli Lilly (1 Trials) |
|
| AM0003 / Eli Lilly (0 Trials) |
|
| AM003 / Aummune (0 Trials) |
|
| AM105 / AbClon (0 Trials) |
|
| AM1710 / MAKScientific, Tetra Bio-Pharma (0 Trials) |
|
| AM211 / Panmira (0 Trials) |
|
| AM230 / AnaMar (0 Trials) |
|
| AM240 / AcurePharma, AnaMar (0 Trials) |
|
| AM3301 / Kemin, Meiji Seika (0 Trials) |
|
|